Ignite Creation Date:
2024-05-05 @ 11:24 AM
Last Modification Date:
2024-10-26 @ 9:07 AM
Study NCT ID:
NCT00032994
Status:
COMPLETED
Last Update Posted:
2017-01-12
First Post:
2002-04-05
Brief Title:
Motivational Interviewing to Improve Treatment Engagement and Outcome in Subjects Seeking Treatment for Substance Abuse - 1
Sponsor:
Yale University
Organization:
National Institute on Drug Abuse NIDA
Study Overview
Official Title:
Motivational Interviewing MI to Improve Treatment Engagement and Outcome in Subjects Seeking Treatment for Substance Abuse
Status:
COMPLETED
Status Verified Date:
2010-04
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to assess Motivational Interviewing MI to improve treatment engagement and outcome in subjects seeking treatment for substance abuse
Detailed Description:
Participants seeking treatment at the participating CTPs will be randomly assigned to either standard or METMI treatment with a 1- and 3-month follow-up Primary outcome measures will include 1 treatment retention eg number of sessionsweeks completed the rate of patients completing 3 or more subsequent sessions and 2 substance use eg urinalyses days of opioid cocaine marijuana alcohol use rates of abstinence Secondary outcomes will include motivation psychosocial functioning HIV risk behaviors treatment utilization and patient satisfaction Process assessments will include measures of the working alliance as well as therapist adherencecompetence ratings which will evaluate how effectively METMI was implemented Participating CTPs will implement one of two independent protocols depending on which is the best suited or feasible for the intake procedures at their clinic Thus following an invitation to participate explanation of the study and provision of informed consent patients would complete a brief assessment battery followed by either1 Random assignment to 3 individual sessions of standard treatment treatment as usual at the program versus 3 individual sessions of MET or 2 Random assignment to 1 individual standard assessmentevaluation session
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None